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1. INTRODUCTION {#cas13873-sec-0001}
===============

Malignant lymphoma is the most common hematological malignancy. As indicated by the existence of more than 80 subtypes in the current World Health Organization classification, the disease is quite heterogeneous.[1](#cas13873-bib-0001){ref-type="ref"} In terms of B‐cell lymphoma, application of anti‐CD20 monoclonal antibodies targeting common B‐cell antigens has improved clinical outcomes for the disease.[2](#cas13873-bib-0002){ref-type="ref"}, [3](#cas13873-bib-0003){ref-type="ref"}, [4](#cas13873-bib-0004){ref-type="ref"} However, about half of patients with malignant lymphoma show refractory disease, and dealing with intractable cases thus continues to be a priority.

Many recent studies have indicated that genetic abnormalities of *MYC* and *BCL2* in tumor cells are closely associated with the poor prognosis of B‐cell lymphoma.[5](#cas13873-bib-0005){ref-type="ref"}, [6](#cas13873-bib-0006){ref-type="ref"}, [7](#cas13873-bib-0007){ref-type="ref"}, [8](#cas13873-bib-0008){ref-type="ref"} In contrast, as shown by the clinical efficacies of anti‐programmed cell death protein 1 (anti‐PD1) antibody for Hodgkin lymphoma (HL) and extranodal natural killer (NK)/T‐cell lymphoma, the tumor microenvironment (TME) is deeply involved in susceptibility to chemotherapies.[9](#cas13873-bib-0009){ref-type="ref"}, [10](#cas13873-bib-0010){ref-type="ref"}, [11](#cas13873-bib-0011){ref-type="ref"} The TME comprises tumor cells and multiple non‐cancerous cells, including fibroblasts, endothelial cells, pericytes, and immunoregulatory cells surrounding neoplastic cells.[12](#cas13873-bib-0012){ref-type="ref"} Interactions between tumor cells and non‐cancerous cells develop a favorable microenvironment for tumor cells, resulting in the acquisition of resistance to various therapies.[13](#cas13873-bib-0013){ref-type="ref"}

Fibroblasts are known to represent one of the key components of tumor stroma, and many studies have suggested a prominent functional role for cancer progression and metastasis.[12](#cas13873-bib-0012){ref-type="ref"}, [14](#cas13873-bib-0014){ref-type="ref"} Fibroblasts associated with cancer are activated and have been termed cancer‐associated fibroblasts (CAF). In the TME of various tumors, humoral factors released from CAF play fundamental roles in tumor metastasis, resistance to chemotherapy, and epithelial‐to‐mesenchymal transition (EMT).[15](#cas13873-bib-0015){ref-type="ref"}, [16](#cas13873-bib-0016){ref-type="ref"}, [17](#cas13873-bib-0017){ref-type="ref"}, [18](#cas13873-bib-0018){ref-type="ref"}, [19](#cas13873-bib-0019){ref-type="ref"}, [20](#cas13873-bib-0020){ref-type="ref"} In malignant lymphoma, we have previously reported that a mouse‐derived fibroblastic reticular cell (FRC) line supported lymphoma cells from patient‐derived xenograft (PDX) models, indicating that fibroblasts also play many functional roles in the lymphoma microenvironment.[21](#cas13873-bib-0021){ref-type="ref"}, [22](#cas13873-bib-0022){ref-type="ref"} This report examined how CAF isolated from primary lymphoma samples support primary lymphoma cells in vitro and clarified the components vital for these abilities.

2. MATERIALS AND METHODS {#cas13873-sec-0002}
========================

2.1. Patient samples {#cas13873-sec-0003}
--------------------

Samples from patients who received lymph node biopsies were obtained at Nagoya University Hospital. The study protocol for the experimental use of patient samples was approved by the institutional review board of Nagoya University Hospital and complied with all provisions of the Declaration of Helsinki and the Ethics Guidelines for Human Genome/Gene Analysis Research issued by the Ministry of Health, Labour and Welfare in Japan. All lymph node samples for banking and analyses were obtained from patients with lymphoid malignancies, after obtaining written informed consent.

2.2. Establishment of patient‐derived CAF {#cas13873-sec-0004}
-----------------------------------------

Patient‐derived CAF were established as described previously.[22](#cas13873-bib-0022){ref-type="ref"} In brief, residue from a fresh patient sample mashed to obtain a cell suspension for diagnostic analyses was loosened in 0.25% trypsin‐EDTA solution, then placed into a 10‐cm dish with Iscove\'s modified Dulbecco\'s medium (Sigma‐Aldrich, St Louis, MO, USA) supplemented with 10% FBS (Gibco in Thermo Fisher Scientific, Waltham, MA, USA) and 2 mmol/L glutamine (Gibco). Of the various types of cells in this culture, only those spindle‐shaped adherent cells with α‐smooth muscle actin (SMA)‐positive, CD31‐negative results survived for more than several months. As such adherent cells were not established from benign disease samples, the adherent cells were regarded as CAF. CAF were maintained in RPMI 1640 Medium (Sigma‐Aldrich) supplemented with FBS and glutamine as mentioned above by splitting them once a week.

2.3. Expansion of primary tumor samples {#cas13873-sec-0005}
---------------------------------------

Primary tumor samples were expanded as follows. Fresh patient samples were mashed and filtered through 70‐μm culture mesh, followed by coculture with the established CAF in the above‐mentioned RPMI culture medium. Whole non‐adherent samples were serially cocultured with the CAF split once a week. After about 1 month, subsets of non‐adherent cells were expanded, which were confirmed as B‐cell lymphoma cells by flow cytometry. The expanded tumor cells were maintained by coculture with CAF, and experiments using the expanded tumor cells were carried out within 1 month.

2.4. Isolation of tumor cells {#cas13873-sec-0006}
-----------------------------

Primary B‐cell lymphoma cells or reactive B‐cell counterparts were magnetically isolated from frozen samples using CD19 beads (Miltenyi Biotec, Bergisch Gladbach, Germany).

2.5. RNA preparation and RT‐PCR {#cas13873-sec-0007}
-------------------------------

To evaluate expressions of monocarboxylate transporter (MCT) genes including *MCT1*,*MCT2*,*MCT3*,*MCT4*,*SMCT1*, and *SMCT2*, and *GAPDH* as an internal control, total RNA from patient cells was extracted using QIAamp RNA Blood Mini Kit (QIAGEN, Venlo, the Netherlands), then cDNA was prepared using SuperScript II Reverse Transcriptase (Invitrogen in Thermo Fisher Scientific) according to the manufacturer\'s protocol. To detect the above genes, the primers listed in Table [S1](#cas13873-sup-0004){ref-type="supplementary-material"} were used. Messenger RNA fragments of *MCT1*,*MCT2*,*MCT3*,*MCT4*,*SMCT1*,*SMCT2* and *GAPDH* were amplified with GoTaq Green (Promega, Madison, MI, USA) using an ABI 3500 genetic analyzer (Applied Biosystems in Thermo Fisher Scientific).

2.6. Immunoblotting {#cas13873-sec-0008}
-------------------

Immunoblotting was carried out using the following antibodies appropriately diluted in TBS‐Tween buffer containing 5% BSA and 0.05% sodium azide: anti‐cleaved caspase 3 (CC3) (clone 5A1E; Cell Signaling Technology, Danvers, MA, USA), anti‐γH2A.X (S139) ([GTX127340](GTX127340); GeneTex, Irvine, CA, USA), and anti‐GAPDH (sc‐25778; Santa Cruz Biotechnology, Dallas, TX, USA). The experimental procedures have been described previously.[23](#cas13873-bib-0023){ref-type="ref"} Images were obtained using a LAS4000mini bio‐imager (FUJIFILM, Tokyo, Japan) and analyzed using MultiGauge software (FUJIFILM).

2.7. Cell death assessment {#cas13873-sec-0009}
--------------------------

To evaluate cell death for monocultured tumor cells, propidium iodide (PI) and annexin V‐FITC assay were carried out as detailed previously.[23](#cas13873-bib-0023){ref-type="ref"}, [24](#cas13873-bib-0024){ref-type="ref"} In brief, cells were placed in 96‐well plates and incubated with the required drugs or pyruvate for the appropriate time, then stained with 10 μg/mL PI and 10 μg/mL annexin V‐FITC for 15 minutes at 4°C in the dark. Cell death was assessed by flow cytometry (FACSCalibur; Becton, Dickinson and Co. (BD), Franklin Lakes, NJ, USA) and analyzed using FlowJo version 10.3 software (TreeStar, Ashland, OR, USA).

2.8. Surface antigens and intracellular antigen analysis {#cas13873-sec-0010}
--------------------------------------------------------

Surface staining was carried out at 4°C using the following antibodies: anti‐intercellular adhesion molecule 1 (ICAM1) (clone 15.2; Bio‐Rad Laboratories, Hercules, CA, USA), anti‐vascular cell adhesion protein 1 (VCAM1) (clone 1.G11B1; Bio‐Rad Laboratories), anti‐CD44 (clone IM7; BioLegend, San Diego, CA), anti‐CD45 (clone HI30; BD), anti‐CD31 (clone MEM‐05; EXBIO, Vestec, Czech Republic), anti‐CD21 (clone Bu32; BioLegend), and anti‐CD35 (clone E11; BioLegend). For intracellular staining, samples were fixed in 4% paraformaldehyde, followed by permeabilization in 0.1% Triton X‐100. Samples were then intracellularly stained with anti‐αSMA (clone 1A4; R&D Systems, Minneapolis, MN, USA) at 4°C. Antigens were assessed by flow cytometry as described above.

2.9. Immunohistochemistry {#cas13873-sec-0011}
-------------------------

Formalin‐fixed, paraffin‐embedded tissues of patient samples were evaluated by routine H&E staining and immunohistochemistry using the following primary antibodies: anti‐CD20 (clone L26; Dako, Glostrup, Denmark), anti‐αSMA (Dako), and anti‐CD31 (ab28364; Abcam, Cambridge, UK). The staining procedure for immunohistochemistry was as described previously.[24](#cas13873-bib-0024){ref-type="ref"} Specimens were observed using a BX51 N‐34 microscope (Olympus, Tokyo, Japan), and the photographs were taken with a BZ9000 (Keyence, Osaka, Japan).

2.10. Evaluation of intracellular reactive oxygen species {#cas13873-sec-0012}
---------------------------------------------------------

Levels of intracellular reactive oxygen species (ROS) were measured using 2′,7′‐dichlorofluorescin diacetate (Cayman Chemical, Ann Arbor, MI, USA). After incubation of cells with 1 mmol/L 2′,7′‐dichlorofluorescin diacetate for 30 minutes at 37°C, the supernatant was removed and the cells were incubated with complete media for 1 hour at 37°C. Fluorescence was then measured on the GloMax‐Multi+ Detection System (Promega Biosystems Sunnyvale, Sunnyvale, CA, USA).

2.11. Evaluation of metabolic activities {#cas13873-sec-0013}
----------------------------------------

Metabolic activities were measured using calcein acetoxymethyl ester. After incubation of cells with 1 μmol/L calcein acetoxymethyl ester for 30 minutes at 37°C, fluorescence was measured on the GloMax‐Multi+ Detection System (Promega). Concentrations of intracellular pyruvate or pyruvate in the medium were measured using a Pyruvate Colorimetric/Fluorometric assay kit (BioVision, Milpitas, CA, USA) in accordance with the protocol from the manufacturer. Absorbance was measured on the GloMax‐Multi+ Detection System (Promega). To inhibit MCT, α‐cyano‐4‐hydroxycinnamic acid (4‐CIN) (Sigma‐Aldrich) was used. Cells were incubated with 500 μmol/L 4‐CIN for 12 hours at 37°C, then cells were evaluated by appropriate procedures for each assay.

2.12. Metabolome analysis {#cas13873-sec-0014}
-------------------------

To analyze comprehensive metabolites secreted from CAF, metabolomic analyses were carried out. In brief, intracellular metabolites were extracted with methanol. Culture supernatants or cell extracts were dried in vacuum and re‐solubilized in Milli‐Q water (Merck Millipore, Billerica, MA, USA) for capillary electrophoresis‐time‐of‐flight mass spectrometry (CE‐TOFMS) analysis. Metabolite analysis using a CE‐TOFMS system[25](#cas13873-bib-0025){ref-type="ref"} was carried out by Human Metabolome Technologies (Tsuruoka, Japan). Concentrations of metabolites were determined from corresponding peak areas normalized to those of the internal standard (H3304‐1002; Human Metabolome Technologies) using three‐point calibration curves.

2.13. High‐performance liquid chromatography analysis {#cas13873-sec-0015}
-----------------------------------------------------

To determine the quantities of specific metabolites in supernatants of CAF, HPLC analyses were also carried out. Supernatants of CAF cultures were mixed with the internal standard 2‐oxovalerate and reacted with 10 mmol/L *o*‐phenylenediamine in 2‐mol/L HCl for 20 minutes at 80°C. Samples were desiccated with sodium sulfate, dried in vacuum, and re‐solubilized in methanol for HPLC analysis. Fluorescent derivatives were separated on an HPLC system comprising a pump (PU‐1580; JASCO, Tokyo, Japan), an auto sampler (AS920; JASCO), a column oven (CO980; JASCO), and a fluorescence detector (FP1520; JASCO). HPLC was carried out on an octadecylsilica column (Inertsil ODS‐4, 250 × 3.0 mm internal diameter, 5 μm; GL Sciences, Tokyo, Japan) at 40°C with a flow rate of 0.6 mL/min, using a mobile phase comprising water/methanol (55/45, v/v).

2.14. Statistical analysis {#cas13873-sec-0016}
--------------------------

Quantitative results using available cell lines or primary lymphoma cells are presented as mean ± standard error of the mean or SD taken from two or three independent experiments. When repeated experiments were difficult using limited primary samples, data were taken from a single experiment. The statistical significance of in vitro experiments was evaluated using an unpaired *t*‐test or by two‐way analysis of variance, with values of *P *\<* *.05 considered significant. All statistical analyses were done using R software (R Foundation for Statistical Computing, Vienna, Austria) or GraphPad PRISMv7 (GraphPad Software Inc., La Jolla, CA, USA).

3. RESULTS {#cas13873-sec-0017}
==========

3.1. Isolation of CAF from primary patient samples with lymphoid malignancies {#cas13873-sec-0018}
-----------------------------------------------------------------------------

At least in part of primary patients' samples, adherent cells could be initiated to proliferate on the bottom of the dish (Figure [1](#cas13873-fig-0001){ref-type="fig"}A). Representative pathological specimens for which adherent cells were able to be cultured at an early stage in our study are shown in Figure [1](#cas13873-fig-0001){ref-type="fig"}B. For lymph nodes (LN) of two patients (Pt)\#1 and Pt\#2, the structure of lymphoid follicles was retained and outgrowth of CD20‐positive tumor cells was seen to lead to the diagnosis of follicular lymphoma (Figure [1](#cas13873-fig-0001){ref-type="fig"}B; Table [S2](#cas13873-sup-0004){ref-type="supplementary-material"}). Continued culture of adherent cells proliferating on the bottom of the dish allowed successful isolation of fibroblasts (Figure [1](#cas13873-fig-0001){ref-type="fig"}C). Isolated fibroblasts could be cultured for a long time, and flow cytometric analysis showed that those fibroblasts were positive for αSMA, activated myoblast markers, and negative for CD31, vascular endothelial markers, indicating that the characteristics of these fibroblasts coincided with those of CAF (Figure [1](#cas13873-fig-0001){ref-type="fig"}D).[12](#cas13873-bib-0012){ref-type="ref"} Other surface phenotypes of those fibroblasts were negativity for CD45, CD21, CD35, and VCAM1, and positivity for ICAM1 and CD44 (Figure [S1](#cas13873-sup-0004){ref-type="supplementary-material"}). Fluorescent immunohistochemical staining for pathological specimens showed that αSMA‐positive fibroblasts and CD31‐positive blood vessels existed around neoplastic follicles (Figure [1](#cas13873-fig-0001){ref-type="fig"}E). To expand our considerations, we continued to culture other lymphoma samples. Fibroblasts were isolated from seven patients with lymphoma (Table [S2](#cas13873-sup-0004){ref-type="supplementary-material"}). All cells showing positive results for αSMA were considered to represent CAF (Figure [1](#cas13873-fig-0001){ref-type="fig"}F). CAF that were culturable for more than 2‐3 months were isolated from neoplastic lymph nodes only, not from reactive tissue (data not shown).

![Establishment of cancer‐associated fibroblasts (CAF) from primary patient lymph node samples. A, Scheme for establishment of primary lymph node samples. B, Pathological specimens of lymph node samples (LN\#1 and LN\#2) are shown. H&E and CD20 staining of LN\#1 (upper left and lower left columns) and LN\#2 (upper right and lower right columns) are shown. Representative CAF\#1 and CAF\#2 originated from these lymph node samples, respectively. Scale bar, 1 mm. C, Phase‐contrast images of representative CAF\#1 (left) and CAF\#2 (right) are shown. Scale bar, 100 μm. D, Expression of surface antigens of CAF evaluated on flow cytometry (FCM). Expression of surface antigens was analyzed using anti‐α smooth muscle actin (anti‐αSMA) (left) and anti‐CD31 (right) antibodies. Isotype‐matched controls are shown as filled histograms. E, Immunofluorescence staining of pathological specimens of LN\#1 and LN\#2. Specimens were analyzed using anti‐αSMA (green) and anti‐CD31 (red) antibodies; anti‐αSMA (upper left and upper right), anti‐CD31 (middle left and middle right), and merged (lower left and lower right). Scale bar, 1 mm. F, Expression of αSMA of established CAF. Established CAF (CAF\#1 to CAF\#7) were evaluated on FCM using anti‐αSMA](CAS-110-269-g001){#cas13873-fig-0001}

3.2. Support of tumor cell survival by CAF {#cas13873-sec-0019}
------------------------------------------

We have previously reported that the BLS4 mouse FRC line, which was established from a mouse lymph node,[26](#cas13873-bib-0026){ref-type="ref"} enabled culture of PDX lymphoma cells[21](#cas13873-bib-0021){ref-type="ref"} and that CAF also supported survival of primary patient lymphoma cells in vitro.[22](#cas13873-bib-0022){ref-type="ref"} Primary patient lymphoma cells (Pt\#8 with Burkitt lymphoma, and Pt\#9 with high‐grade B‐cell lymphoma, not otherwise specified) could proliferate in coculture with CAF\#1 and CAF\#2 in vitro, whereas neither cell type could survive in monoculture (Figure [2](#cas13873-fig-0002){ref-type="fig"}A,B; Table [S2](#cas13873-sup-0004){ref-type="supplementary-material"}). For immunoblotting to evaluate cell death, higher expression of γH2A.X and cleaved caspase 3 resulting from DNA double‐strand breaks in lymphoma cells leading to apoptosis were detected in monoculture (Figure [2](#cas13873-fig-0002){ref-type="fig"}C). We next expanded the analysis to determine whether three different types of primary B‐cell lymphoma cells from lymph node biopsies could survive in coculture with CAF. Survival of primary lymphoma cells in coculture with CAF differed among histological subtypes; survival support was observed in both of two primary diffuse large B‐cell lymphoma (DLBCL) cells and in one of two primary follicular lymphoma (FL) cells. The remaining primary lymphoma cells from a patient with marginal zone B‐cell lymphoma (MZBCL) were not supported (Figure [2](#cas13873-fig-0002){ref-type="fig"}D; Table [S2](#cas13873-sup-0004){ref-type="supplementary-material"}). In addition, we analyzed whether survival support from CAF differed among lineages of lymphoma cells. Intriguingly, primary lymphoma cells could survive irrespective of lineage, including B cells and T cells (Figure [2](#cas13873-fig-0002){ref-type="fig"}E; Table [S2](#cas13873-sup-0004){ref-type="supplementary-material"}). We thus hypothesized that some types of humoral factors from CAF were associated with such support of survival for primary lymphoma cells. Survival support of primary B‐cell lymphoma cells (Pt\#1, Pt\#2, Pt\#5, and Pt\#6; numbers indicating each patient match with corresponding CAF in Table [S2](#cas13873-sup-0004){ref-type="supplementary-material"}) was analyzed in culture with conditioned medium with CAF or in the absence of direct contact between CAF and lymphoma cells using separation by a Transwell with a pore size of 0.4 μm (Figure [2](#cas13873-fig-0002){ref-type="fig"}F). As expected, survival support from CAF was observed not only in the presence of direct contact between tumor cells and CAF, but also in the absence of direct contact and under coculture in conditioned medium with CAF (Figure [2](#cas13873-fig-0002){ref-type="fig"}G). In terms of redox regulation, intracellular ROS uniformly decreased in the presence of direct or indirect contact between CAF and lymphoma cells (Figure [2](#cas13873-fig-0002){ref-type="fig"}H). The extent of survival support in patient lymphoma cells varied according to the type of support from CAF. Analyzed from the perspective of conditioned medium released from matched or unmatched CAF with the corresponding patient lymphoma cells, we could not detect apparent differences in ROS production (Figure [2](#cas13873-fig-0002){ref-type="fig"}I). Survival of lymphoma cells cultured with conditioned medium released from CAF from the corresponding patient varied, but was higher than survival with normal complete media (Figure [2](#cas13873-fig-0002){ref-type="fig"}J). In addition, the increased survival of lymphoma cells cultured with conditioned medium contributed to resistance to the anticancer drug doxorubicin (Figure [2](#cas13873-fig-0002){ref-type="fig"}K). Collectively, these data indicate that humoral factors from CAF could be involved in survival support of patient lymphoma cells.

![Cancer‐associated fibroblasts (CAF) and conditioned media support survival of primary lymphoma cells. A, Scheme of coculture of primary lymphoma cells with CAF. B, Proliferation of primary lymphoma cells (Pt\#8, left; Pt\#9, right) in monoculture (open circle) and coculture with CAF\#1 (circle) and CAF\#2 (square). Survival of tumor cells was evaluated by Trypan blue exclusion. Each point represents the mean value taken from three independent experiments with error bars indicating the standard error of the mean. C, Immunoblotting for γH2A.X, CC3, and GAPDH as a loading control in Pt\#8 and Pt\#9 in monoculture and coculture with CAF\#1 and CAF\#2 was carried out. D, Viability of three histological types of primary B‐cell lymphoma cells (DLBCL, indigo blue; FL, green; MZBCL, brown) in coculture with CAF\#1 (left) and CAF\#2 (right) overnight are shown. Each point represents the mean value of two technical replicates taken from a single experiment. E, Viability of a different lineage of lymph node samples including B‐cell lymphoma (indigo blue), T‐cell lymphoma (green) and others such as related disease or reactive tissue (brown) in coculture with CAF\#1 and CAF\#2 overnight are shown. Each point represents the mean value of two technical replicates taken from a single experiment. F, Scheme of culture in the presence of conditioned medium (CM) released from CAF (left), in the absence of direct contact of primary lymphoma cells to CAF by Transwell (upper right), and coculture with CAF (lower right). G, Comparison of survival of primary B‐cell lymphoma cells (Pt\#2, Pt\#5, Pt\#1, and Pt\#6) in monoculture (white), coculture with CAF (orange), in the absence of direct contact with CAF using the Transwell (green), and in culture with CM released from CAF (blue) overnight are shown. CAF originated from samples corresponding to the examined lymphoma cells. Each bar represents averaged data (two technical replicates) taken from a single experiment. H, Comparisons of redox regulation in B‐cell lymphoma cells (Pt\#2, Pt\#5, Pt\#1, and Pt\#6) in monoculture (white), coculture with CAF (orange), in the absence of direct contact with CAF using Transwell (green), and in culture with CM released from CAF (blue) are shown. Levels of intracellular ROS were measured using a fluorescent indicator, 2′,7′‐dichlorofluorescin diacetate. I, Comparisons of redox regulation in B‐cell lymphoma cells (Pt\#2, Pt\#5, Pt\#1, and Pt\#6) in monoculture, and cultures with CM released from CAF\#2, CAF\#5, CAF\#1, and CAF\#6. Blue bars represent mean values for the four conditions. Values of the matched pairs of lymphoma cells and established CAF are indicated as black points, and those of unmatched pairs are indicated as grey points. \**P *\<* *.05, \*\**P *\<* *.01, \*\*\**P *\<* *.001. J, Survival of primary B‐cell lymphoma cells (Pt\#2, Pt\#5, Pt\#1, and Pt\#6) in culture with CM released from the corresponding CAF. Blue bar represents the mean value of the four conditions (Pt\#2, Pt\#5, Pt\#1, and Pt\#6) indicated by black points. K, Survival of primary lymphoma cells (Pt\#9) in the presence of 100 nmol/L doxorubicin in culture with or without CM released from CAF\#2. Cells were treated with doxorubicin for 72 h, before analysis of cell death on flow cytometry. Each bar represents averaged data (two technical replicates) taken from five independent experiments. Error bars indicate SD](CAS-110-269-g002){#cas13873-fig-0002}

3.3. Role of pyruvate released from CAF in survival support {#cas13873-sec-0020}
-----------------------------------------------------------

We next analyzed the metabolites from CAF that contribute to survival support. Among 41 metabolites analyzed using CE‐TOFMS assay, pyruvate was identified as the most increased metabolite secreted into the conditioned medium from CAF (Figure [3](#cas13873-fig-0003){ref-type="fig"}A; Table [S3](#cas13873-sup-0004){ref-type="supplementary-material"}). We also confirmed that pyruvate was secreted into the media at higher concentrations in HPLC (Figure [3](#cas13873-fig-0003){ref-type="fig"}B,C). Addition of pyruvate to culture media contributed significantly to survival of primary DLBCL (n = 9) and FL cells (n = 14) (Figure [3](#cas13873-fig-0003){ref-type="fig"}D). In line with the increased survival seen on addition of pyruvate to culture media, intracellular ROS production was decreased in DLBCL and FL cells (Figure [3](#cas13873-fig-0003){ref-type="fig"}E). We subsequently evaluated the significance of pyruvate released from CAF for primary lymphoma cells by the inhibition of MCT involved in the uptake and efflux of pyruvate. Expression of MCT of tumor cells was initially confirmed (Figure [3](#cas13873-fig-0003){ref-type="fig"}F). In the presence of complete media supplemented with pyruvate, the MCT inhibitor 4‐CIN decreased the concentration of intracellular pyruvate, probably through inhibition of pyruvate uptake from culture media (Figure [3](#cas13873-fig-0003){ref-type="fig"}G). Addition of 4‐CIN to both complete media with pyruvate and conditioned medium from CAF decreased cell survival and increased ROS production (Figure [3](#cas13873-fig-0003){ref-type="fig"}H,I). Moreover, the concentration of pyruvate in the conditioned medium from CAF decreased in the presence of 4‐CIN (Figure [3](#cas13873-fig-0003){ref-type="fig"}J). Together, these data indicate that pyruvate secreted from CAF at high concentration decreased intracellular ROS production by primary lymphoma cells, resulting in survival of these cells. Furthermore, this secretion and the resulting effects were, at least in part, canceled by the inhibition of MCT.

![Pyruvate as the fundamental metabolite in cancer‐associated fibroblasts (CAF). A, Comparison of metabolites between RPMI and conditioned medium (CM) released from CAF\#1 and CAF\#2 evaluated by capillary electrophoresis‐time‐of‐flight mass spectrometry (CE‐TOFMS). Data are sorted by concentrations of metabolites in RPMI. B, Confirmation of release of pyruvate from CAF by HPLC. C, Concentrations of pyruvate released in CM from CAF. Brown bar indicates the mean value of conditioned mediums from CAF\#1 to CAF\#7 measured by HPLC. Each point (black) represents the concentration of pyruvate in CM released from each CAF, as the mean of data from three experiments. D, Comparison of viabilities of primary lymphoma cells (diffuse large B‐cell lymphoma \[DLBCL\], n = 9; follicular lymphoma \[FL\], n = 14; and reactive tissues, n = 4) in the presence or absence of 0.25 mmol/L pyruvate is shown. Viability was evaluated by the propidium iodide (PI)‐Annexin V method on flow cytometry (FCM). Corresponding samples in the presence or absence of pyruvate are connected with a straight line. Each point represents the mean of two individual technical replicates taken from a single experiment. \**P *\<* *.05, \*\**P *\<* *.01, \*\*\**P *\<* *.001, \*\*\*\**P *\<* *.0001. E, Comparison of redox regulation in primary lymphoma cells (DLBCL, n = 9; FL, n = 14; reactive tissues, n = 5) in the presence or absence of 0.25 mmol/L pyruvate. Each bar indicates the mean value of primary lymphoma samples indicated taken from a single experiment (two technical replicates) with error bar indicating SD. F, RT‐PCR analysis of monocarboxylate transporter (MCT;*MCT1*,*MCT2*,*MCT3*,*MCT4*,*SMCT1*, and *SMCT2*) in Pt\#9 cells. PCR using primers for GAPDH was carried out as an internal control. G‐I, Significance of the inhibition of MCT by α‐cyano‐4‐hydroxycinnamic acid (4‐CIN) in Pt\#9 cells in culture with RPMI,RPMI on addition of pyruvate, and CM. Relative intracellular pyruvate (G), survival analysis on FCM (H), and relative intracellular ROS (I) are shown. Each bar indicates the mean from three or four independent experiments (two technical replicates) with error bar indicating SD. J, Relative concentration of pyruvate in CM released from CAF\#2 in the presence or absence of 4‐CIN. Each bar indicates the mean taken from four independent experiments (two technical replicates) with error bar indicating SD](CAS-110-269-g003){#cas13873-fig-0003}

3.4. Culture with conditioned medium increases the citric acid cycle in tumor cells {#cas13873-sec-0021}
-----------------------------------------------------------------------------------

Finally, we analyzed the types of metabolites in patient tumor cells that were modulated by culture with conditioned medium. In the presence of conditioned medium from CAF\#1, intermediates in the citric acid cycle including 2‐hydroxyglutarate, succinate, fumarate, and malate increased in patient tumor cells (Pt\#8 and Pt\#9) (Figure [4](#cas13873-fig-0004){ref-type="fig"}A). Metabolic activity in tumor cells was increased in a pyruvate dose‐dependent way (Figure [4](#cas13873-fig-0004){ref-type="fig"}B). These data indicate that pyruvate secreted from CAF increased the citric acid cycle in tumor cells, leading to cell survival.

![Increased citric acid cycle in primary lymphoma cells in culture with conditioned medium (CM). A, Scheme of citric acid cycle (left) and increased intermediates in the cycle in lymphoma cells under culture with CM released from CAF\#1 (right). Intermediates were measured by capillary electrophoresis‐time‐of‐flight mass spectrometry. B, Relative metabolic activities in Pt\#8 and Pt\#9 cultured overnight in RPMI medium supplemented with the indicated concentrations of pyruvate are shown. Values were measured using a fluorescent indicator calcein.[27](#cas13873-bib-0027){ref-type="ref"} Each point represents the mean value taken from three independent experiments, with error bars indicating SEM. CAF, cancer‐associated fibroblast](CAS-110-269-g004){#cas13873-fig-0004}

4. DISCUSSION {#cas13873-sec-0022}
=============

In this analysis, we successfully isolated CAF from primary lymph node samples in patients with malignant lymphoma. CAF significantly secreted pyruvate, which might have been taken up by neighboring tumor cells, increasing the citric acid cycle, and leading to decreased redox regulation and survival of tumor cells. Anerobic glycolysis is generally increased in tumor cells, representing the Warburg effect.[28](#cas13873-bib-0028){ref-type="ref"} A previous report showed that epithelial cancer cells induced aerobic glycolysis in stromal fibroblasts, then underwent myo‐fibroblastic differentiation to secrete lactate and pyruvate. Tumor cells then showed uptake of energy‐rich metabolites and used them in the citric acid cycle, recognized as the reverse Warburg effect.[29](#cas13873-bib-0029){ref-type="ref"} Our findings might support this effect existing not only in epithelial tumor cells, but also in lymphoma cells.

In the present study, we were able to isolate CAF from various types of lymphoid malignancies, including DLBCL, FL, and HL. Considering that long‐term culture of fibroblasts from reactive lymph nodes was considered impossible, fibroblasts are widely activated as CAF in malignant lymphoid tumors irrespective of the histological type. However, we observed differences in survival support between histological types. We used CAF\#1 and CAF\#2, which showed strong support of tumor cell survival in this analysis. DLBCL cells tended to be supported by CAF, whereas survival support was not apparent for FL and MZBCL cells. As the difference in survival support between lineages of tumor cells was unclear, the nature of tumor cells in terms of the rate of cell proliferation may be associated with survival support.

In this analysis, the value of survival support by CAF differed between primary lymphoma cells. However, the support of tumor cell survival did not differ according to the presence or absence of direct contact of tumor cells to stromal cells; that is, survival did not differ significantly among cocultures, cocultures in Transwells, and cultures with conditioned medium from CAF. Moreover, redox regulation in tumor cells did not differ according to the presence of conditioned medium from different CAF (Figure [2](#cas13873-fig-0002){ref-type="fig"}I). These findings suggest that humoral factors released from CAF might be critical for support of tumor cell survival. The mechanisms underlying the differences between primary lymphoma cells and the nature of CAF from lymph node samples should be further investigated.

Metabolome analysis showed that pyruvate secreted from CAF plays an important role in supporting tumor cells. Intriguingly, the extent of support of DLBCL cell survival in cocultures with CAF was superior to that of FL cell survival, whereas the extent of FL cell survival support in culture with medium supplemented with pyruvate or conditioned medium from CAF was superior to that of DLBCL cell survival. This discrepancy might be as a result of differences in the nature of tumor cells such as proliferation and dependency on TME. In addition, inhibition of uptake/efflux of pyruvate by the MCT inhibitor 4‐CIN decreased survival or increased intracellular ROS production by lymphoma cells. In contrast, the concentration of intracellular pyruvate in lymphoma cells increased in the presence of conditioned medium from CAF with 4‐CIN. This paradoxical phenomenon might be a consequence of the inhibition of efflux of intracellular pyruvate. This discrepancy should be further investigated.

In the present analysis, reliance on the citric acid cycle in tumor cells increased in cultures with conditioned medium from CAF. Generally, the TME is known to be under hypoxic conditions and promotes a metabolic switch in tumor cells away from mitochondrial respiration to glycolysis.[28](#cas13873-bib-0028){ref-type="ref"} According to our previous report, tumor cells in coculture with CAF promote anaerobic glycolysis as indicated by the increased expressions of HK2 and PDK1.[22](#cas13873-bib-0022){ref-type="ref"} Considering the complexity in terms of energy production in tumor cells, tumor cells might coordinate the regulation of aerobic glycolysis and the citric acid cycle according to the specific TME.[30](#cas13873-bib-0030){ref-type="ref"}, [31](#cas13873-bib-0031){ref-type="ref"}, [32](#cas13873-bib-0032){ref-type="ref"} Clarification of associations between metabolic changes and survival of lymphoma cells represents an interesting topic for future analyses.

In conclusion, we successfully isolated CAF from primary lymph node samples from patients with different types of lymphoma. Pyruvate secreted from CAF appears to play an important role in the survival of tumor cells. Considering that CAF carry out various functions in the TME, the findings of this study could represent only a fraction of what occurs in the TME. Future investigations to uncover the role of CAF in the lymphoma microenvironment may provide a gateway to overcoming this intractable disease.
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